tiprankstipranks
Trending News
More News >
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Income Statement

Compare
542 Followers

Relay Therapeutics Income Statement

Last quarter (Q3 2025), Relay Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Relay Therapeutics's net income was $-74.15M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.01M$ 25.55M$ 1.38M$ 3.03M$ 82.65M
Gross Profit
$ 10.01M$ 25.55M$ 1.38M$ 3.03M$ 79.11M
Operating Expenses
$ 382.48M$ 398.55M$ 300.66M$ 367.73M$ 134.90M
Depreciation and Amortization
$ 5.46M$ 5.27M$ 4.13M$ 3.92M$ 3.55M
EBITDA
$ -380.21M$ -374.15M$ -306.82M$ -223.08M$ -52.25M
Operating Income
$ -372.47M$ -373.00M$ -299.27M$ -364.70M$ -55.80M
Other Income/Expenses
$ 34.76M$ 31.03M$ 8.77M$ 826.00K$ 3.38M
Pretax Income
$ -337.71M$ -341.97M$ -290.51M$ -363.87M$ -52.41M
Net Income
$ -337.71M$ -341.97M$ -290.51M$ -363.87M$ -52.41M
Per Share Metrics
Basic EPS
$ -2.36$ -2.79$ -2.59$ -3.82$ -2.56
Diluted EPS
$ -2.36$ -2.79$ -2.59$ -3.82$ -2.56
Weighted Average Shares Outstanding
142.87M 122.58M 112.23M 95.14M 90.05M
Weighted Average Shares Outstanding (Diluted)
142.87M 122.58M 112.23M 95.14M 90.19M
Currency in USD

Relay Therapeutics Earnings and Revenue History